Literature DB >> 26680678

Is the amount of coronary perivascular fat related to atherosclerosis?

I Kralova Lesna1, Z Tonar, I Malek, J Maluskova, L Nedorost, J Pirk, J Pitha, V Lanska, R Poledne.   

Abstract

Interesting and stimulating data about the effect of the perivascular adipose tissue size on atherogenesis are based mainly on CT findings. We studied this topic by directly analyzing perivascular adipose tissue in explanted hearts from patients undergoing transplantation. Ninety-six consecutive patients were included, including 58 with atherosclerotic coronary heart disease (CHD) and 38 with dilation cardiomyopathy (DCMP). The area of perivascular fat, area of the coronary artery wall, and ratio of CD68-positive macrophages within the perivascular fat and within the vascular wall were quantified by immunohistochemistry. There was no significant difference in the perivascular adipose tissue size between the two groups. Nevertheless, there was a significantly higher number of macrophages in the coronary arterial wall of CHD patients. In addition, we found a close relationship between the ratio of macrophages in the arterial wall and adjacent perivascular adipose tissue in the CHD group, but not in the DCMP group. According to our data interaction between macrophages in the arterial wall and macrophages in surrounding adipose tissue could be more important mechanism of atherogenesis than the size of this tissue itself.

Entities:  

Mesh:

Year:  2015        PMID: 26680678     DOI: 10.33549/physiolres.933151

Source DB:  PubMed          Journal:  Physiol Res        ISSN: 0862-8408            Impact factor:   1.881


  8 in total

Review 1.  Role of Inflammation in Vascular Disease-Related Perivascular Adipose Tissue Dysfunction.

Authors:  Yaozhi Chen; Zeyu Qin; Yaqiong Wang; Xin Li; Yang Zheng; Yunxia Liu
Journal:  Front Endocrinol (Lausanne)       Date:  2021-08-11       Impact factor: 5.555

Review 2.  Perivascular adipose tissue: An unique fat compartment relevant for the cardiometabolic syndrome.

Authors:  D I Siegel-Axel; H U Häring
Journal:  Rev Endocr Metab Disord       Date:  2016-03       Impact factor: 6.514

3.  Inflammatory cells in perivascular adipose tissue and the integrity of the tunica media in atherosclerotic coronary arteries.

Authors:  Ruda Zorc-Pleskovič; Marjeta Zorc; Dušan Šuput; Aleksandra Milutinović
Journal:  Bosn J Basic Med Sci       Date:  2020-05-01       Impact factor: 3.363

4.  B Lymphocytes and Macrophages in the Perivascular Adipose Tissue Are Associated With Coronary Atherosclerosis: An Autopsy Study.

Authors:  Daniela Souza Farias-Itao; Carlos Augusto Pasqualucci; Aline Nishizawa; Luiz Fernando Ferraz da Silva; Fernanda Marinho Campos; Márcio Sommer Bittencourt; Karen Cristina Souza da Silva; Renata Elaine Paraízo Leite; Lea Tenenholz Grinberg; Renata Eloah de Lucena Ferretti-Rebustini; Wilson Jacob-Filho; Claudia Kimie Suemoto
Journal:  J Am Heart Assoc       Date:  2019-12-10       Impact factor: 5.501

5.  Canagliflozin Prevents Diabetes-Induced Vascular Dysfunction in ApoE-Deficient Mice.

Authors:  Arief Rahadian; Daiju Fukuda; Hotimah Masdan Salim; Shusuke Yagi; Kenya Kusunose; Hirotsugu Yamada; Takeshi Soeki; Masataka Sata
Journal:  J Atheroscler Thromb       Date:  2020-02-26       Impact factor: 4.928

Review 6.  Exploring the Relationship of Perivascular Adipose Tissue Inflammation and the Development of Vascular Pathologies.

Authors:  Afifah Zahirah Abd Rami; Adila A Hamid; Nur Najmi Mohamad Anuar; Amilia Aminuddin; Azizah Ugusman
Journal:  Mediators Inflamm       Date:  2022-02-08       Impact factor: 4.711

7.  Human Perivascular Adipose Tissue as a Regulator of the Vascular Microenvironment and Diseases of the Coronary Artery and Aorta.

Authors:  Caitlin Stieber; Kimberly Malka; Joshua M Boucher; Lucy Liaw
Journal:  J Cardiol Cardiovasc Sci       Date:  2019-08-13

Review 8.  Adipose Tissue Distribution, Inflammation and Its Metabolic Consequences, Including Diabetes and Cardiovascular Disease.

Authors:  Alan Chait; Laura J den Hartigh
Journal:  Front Cardiovasc Med       Date:  2020-02-25
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.